Nice (France), 8 January 2008 – Iris Pharma of France, a specialist contract research organisation (CRO) for pre-clinical research in ophthalmology, has announced the completion of its merger with 
Clirophtha, a unique CRO in Europe and North America that is completely dedicated to ophthalmology clinical trials. The new entity will be known as Iris Pharma... Iris' Press Release -
